Literature DB >> 16530191

N-myristoyltransferase 2 expression in human colon cancer: cross-talk between the calpain and caspase system.

Ponniah Selvakumar1, Erin Smith-Windsor, Keith Bonham, Rajendra K Sharma.   

Abstract

A number of viral and eukaryotic proteins which undergo a lipophilic modification by the enzyme N-myristoyltransferase (NMT: NMT1 and NMT2) are required for signal transduction and regulatory functions. To investigate whether NMT2 contributes to the pathogenesis of colorectal carcinoma, we observed a higher expression of NMT2 in most of the cases of cancerous tissues compared to normal tissues (84.6% of cases; P < 0.05) by Western blot analysis. Furthermore, protein-protein interaction of NMTs revealed that m-calpain interacts with NMT1 while caspase-3 interacts with NMT2. Our findings provide the first evidence of higher expression of NMT2 in human colorectal adenocarcinomas and the interaction of both forms of NMT with various signaling molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530191     DOI: 10.1016/j.febslet.2006.02.076

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  The complex and important cellular and metabolic functions of saturated fatty acids.

Authors:  Philippe Legrand; Vincent Rioux
Journal:  Lipids       Date:  2010-07-13       Impact factor: 1.880

2.  Protein myristoylation in health and disease.

Authors:  Megan H Wright; William P Heal; David J Mann; Edward W Tate
Journal:  J Chem Biol       Date:  2009-11-07

3.  Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo.

Authors:  B H Meurers; C Zhu; P O Fernagut; F Richter; Y C Hsia; S M Fleming; M Oh; D Elashoff; C D Dicarlo; R L Seaman; M F Chesselet
Journal:  Neurobiol Dis       Date:  2008-10-26       Impact factor: 5.996

4.  Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum.

Authors:  Paul W Bowyer; Ruwani S Gunaratne; Munira Grainger; Chrislaine Withers-Martinez; Sasala R Wickramsinghe; Edward W Tate; Robin J Leatherbarrow; Katherine A Brown; Anthony A Holder; Deborah F Smith
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

5.  N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target.

Authors:  John R Mackey; Luc G Berthiaume; Justine Lai; Utkarsh Chauhan; Erwan Beauchamp; Wei-Feng Dong; Darryl Glubrecht; Yie-Wei Sim; Sunita Ghosh; Gilbert Bigras; Raymond Lai
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

6.  Biochemical characterization of bovine brain myristoyl-CoA:protein N-myristoyltransferase type 2.

Authors:  Ponniah Selvakumar; Ashakumary Lakshmikuttyamma; Rajendra K Sharma
Journal:  J Biomed Biotechnol       Date:  2009-09-02

7.  Rapid detection, discovery, and identification of post-translationally myristoylated proteins during apoptosis using a bio-orthogonal azidomyristate analog.

Authors:  Dale D O Martin; Gonzalo L Vilas; Jennifer A Prescher; Gurram Rajaiah; John R Falck; Carolyn R Bertozzi; Luc G Berthiaume
Journal:  FASEB J       Date:  2007-10-10       Impact factor: 5.191

8.  Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme.

Authors:  Michael P Marciel; Aaron H Rose; Verena Martinez; David T Horio; Ann S Hashimoto; FuKun W Hoffmann; Pietro Bertino; Peter R Hoffmann
Journal:  Cancer Med       Date:  2017-12-06       Impact factor: 4.452

9.  Targeting N-myristoylation for therapy of B-cell lymphomas.

Authors:  Erwan Beauchamp; Megan C Yap; Aishwarya Iyer; Maneka A Perinpanayagam; Jay M Gamma; Krista M Vincent; Manikandan Lakshmanan; Anandhkumar Raju; Vinay Tergaonkar; Soo Yong Tan; Soon Thye Lim; Wei-Feng Dong; Lynne M Postovit; Kevin D Read; David W Gray; Paul G Wyatt; John R Mackey; Luc G Berthiaume
Journal:  Nat Commun       Date:  2020-10-22       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.